Estrella Immunopharma ESLA Estimates

NASDAQ ESLA
$0.47 +0.01 (+1.78%)
At close: Oct 1, 2026 · 4:00 PM EDT
Analyst Estimates

Estrella Immunopharma, Inc. Quarterly Revenue Estimates

Periods 11
Next Period Q3 25
Consensus 0.00

Analysts expect Estrella Immunopharma, Inc. to report revenue of 0.00 for Q3 25, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 0.000.000.00-0.000.000.00----
High Estimate --0.000.000.000.000.000.000.000.000.00
Low Estimate --0.000.000.000.000.000.000.000.000.00
Consensus Estimate --0.000.000.000.000.000.000.000.000.00
Analyst Estimates

Estrella Immunopharma, Inc. Quarterly Earnings Per Share (EPS) Estimates

Periods 12
Next Period Q3 26
Consensus -0.07

Analysts expect Estrella Immunopharma, Inc. to report earnings per share of -0.07 for Q3 26, against a range of -0.08 to -0.06. The most recent reported quarter, Q2 26, came in at -0.05 , in line with the -0.05 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) -0.12-0.12-0.07-0.07-0.19-0.14-0.05-0.05----
High Estimate --0.10-0.10-0.07-0.17-0.15-0.07-0.05-0.06-0.06-0.13-0.10
Low Estimate --0.12-0.12-0.07-0.19-0.19-0.09-0.05-0.08-0.08-0.13-0.12
Consensus Estimate --0.11-0.11-0.07-0.18-0.17-0.08-0.05-0.07-0.07-0.13-0.11

Estrella Immunopharma, Inc. Estimates API

Pull Wall Street consensus for Estrella Immunopharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=ESLA&mode=revenue&api_key=YOUR_API_KEY